The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Inducts advanced AI-Powered 24x7 remote patient monitoring system
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Comprehensive clinical development programs being initiated for each investigational candidate
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Subscribe To Our Newsletter & Stay Updated
